Panel advises FDA to reject Avastin as breast cancer drug

[News]

The unanimous recommendation by this committee of cancer experts increases the likelihood that the drug will no longer be widely available for the treatment of breast cancer. Avastin, however, will continue to have the Food and Drug Adminstration's approval for use in treating certain other cancers.

More... (http://www.news-medical.net/news/20110701/Panel-advises-FDA-to-reject-Avastin-as-breast-cancer-drug.aspx)